Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. [electronic resource]
Producer: 20090904Description: 615-20 p. digitalISSN:- 1532-1827
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain Neoplasms -- drug therapy
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Female
- Glioblastoma -- drug therapy
- Humans
- Interferon Type I -- administration & dosage
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Recombinant Proteins
- Temozolomide
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.